"This is a record of the patient's case and treatment, and the patient has been treated in our hospital since the cancer was diagnosed in our hospital, and about a month ago he had surgery to remove a liver tumor, and then he underwent chemotherapy at our hospital for a month to control his condition. ”

"But 20 days ago, the patient left the hospital and went home despite the doctor's dissuasion," Dr Wang said. Three days ago, the patient went to our hospital for a follow-up examination, and it was found that the focal point had changed again after the operation, and a tumor of 2×3 cm appeared. ”

From a professional point of view, Dr. Wang said, "We can determine that the new tumor in this area is a malignant tumor through color ultrasound. ”

"But it's strange!" Dr. Wang took out the blood biochemical indicators and said, "We found that the malignant tumor has no effect on the body, in other words, the tumor seems to be hanging there and has no effect." ”

After Dr. Wang's introduction, he projected Shuai Zhengguo's case and other information onto the big screen.

The doctors in the oncology department were amazed.

"Although there is still a big gap between blood biochemical indicators and healthy people, it is not the case of a patient with advanced liver cancer. ”

"That's right! These data show that the patient is recovering!"

"Biochemical indicators and color ultrasound indicators diverge. ”

"Is there a mistake with the patient's sample or is there something wrong with our machine?"

The doctors were talking.

Dr. Wang said, "Please don't talk about it yet, I can guarantee that there is no problem with the machine, and there is no problem with the patient's blood sample." ”

"What's going on?"

"It shouldn't be!"

"Is the tumor benign?"

"It's not like cancer. ”

At this time, a doctor asked, "Is it because the patient went overseas for treatment, so his condition has improved?"

"Are you talking about targeted therapy?" said a doctor: "Targeted therapy in the United States may indeed be effective, but blood indicators like this are completely contrary to color ultrasound...... Targeted therapy wouldn't have that effect!"

Just when everyone was arguing endlessly and couldn't understand the reason, Wang Tao, dean of the School of Medicine of Jiangcheng University and professor of the Department of Oncology of the Affiliated Hospital of Jiangcheng University, came to the oncology department.

He said: "Stop arguing, I know this patient. ”

"Dean Wang!"

"Dean Wang is here. ”

Wang Tao said: "He received gene expression suppression therapy from Pangu Technology. This therapy is the latest liver cancer treatment method of Pangu Technology, Pangu Technology has found the genome that expresses the expression of liver cancer genes, and inhibited the cancer expression of the genome by means of means, so that liver cancer does not occur again, and for cells that have been expressed as malignant tumors, it is also used to inhibit the continued expression of tumor genes and let the tumor cells die by themselves. In this way, liver cancer will be treated thoroughly. ”

"Pangu Technology?" exclaimed the doctors.

Someone asked, "Is the Pangu technology you are talking about the Pangu technology from Jiangcheng University?"

"What about the development of domestic operating systems and sewage treatment?"

"Yes!" Wang Tao projected Pangu Technology's treatment plan on the big screen and said, "This is their treatment plan, and the clinical trial has not yet been applied, so the agreement between them and the patient is private." ”

When Wang Tao said this, everyone understood.

It was Dean Wang who gave Pangu Technology a chance and also gave the patients a chance.

"Now we should discuss whether to cooperate with Pangu Technology to incorporate gene expression inhibition therapy into our clinical trials," said Dr. Wang. ”

"This is a chance for the Affiliated Hospital of Jiangcheng University, and it is also a chance for patients. ”

Dean Wang has also been concerned about Shuai Zhengguo's treatment effect, and the current treatment effect is greatly beyond his expectations, if this treatment method is truly applied to the clinic, liver cancer can indeed be saved.

Dean Wang even thinks that the field of transplantation gene expression cancer can continue to be studied, and that the real way for humans to overcome cancer in the future is definitely not in chemoradiotherapy, not in targeted drugs, but in inhibiting gene expression.

The meeting is no longer a problem involving a department, but related to the future of the Affiliated Hospital of Jiangcheng University, in addition to President Wang, other senior executives of the hospital have joined the meeting after receiving the report.

At Xingchen Hospital, the patient's surgery is in full swing.

The experimental team has performed surgery on 15 people, and all of them have been successful.

Making the treatment of malignant tumors simple and easy to operate is the direction that medical workers should strive for.

Zheng Xuanyu completely gave up her summer vacation and devoted herself to the work of the laboratory.

The laboratory does not operate on the patient, but follows up on the treatment of none of the patients, with an initial observation period of six months and a long-term observation period of three to five years.

After half a year, if the patient's condition does not recur and the liver no longer has malignant tumors, then it can be concluded that the experiment is temporarily successful, and after three or five years, the patient's life expectancy has been exceeded, and the patient's quality of life has not been affected, then the experiment can be concluded to be successful.

Zheng Xuanyu studied medical experiments, and did bring a kind of fresh blood to the laboratory in terms of medical experiment methods and statistics, Gao Siqi valued it very much, and even directly asked Xiao Ming if he could let Zheng Xuanyu transfer to Jiangcheng University.

Xiao Ming smiled, which also shows that the undergraduates who can be favored by the molecular medicine laboratory of Yenching University do still have considerable strength.

At the end of July, most of the patients had just completed the operation for less than half a month or even a week, and many people's malignant tumors had not disappeared, but the patients had seen hope for life.

They don't have the physical discomfort of chemoradiation in the hospital, they don't have the weakness after surgery, or even the physiological changes that come with liver changes.

After the treatment, the patients felt that they did not have liver cancer at all, and they felt that they were no different from ordinary people.

Sun Cheng is 48 years old and has stage II liver cancer, and is fortunate to be one of the volunteers.

After being diagnosed with liver cancer eight years ago, Sun Cheng updated a weekly log on Weibo, mainly to encourage himself not to lose the courage to live.

This desire for life and positive and optimistic spirit have also brought Sun Cheng more than 300,000 fans. These fans include ordinary netizens and patients, and fans are moved by Sun Cheng's spirit, and many people raise donations for him.

Sun Cheng, who is not in a bad economic condition, has tried the world's most advanced treatment methods, including targeted drugs in the United States and a new generation of targeted drugs being developed in the medical laboratory of Stanford University.

It's a pity that none of these drugs can save Sun Cheng's gradually dying life, until Sun Cheng meets Pangu Technology.

Sun Cheng also posted his treatment with Pangu Technology on Weibo, which attracted strong attention from the patient circle.

Many liver cancer patients across the country have left messages on Sun Cheng's Weibo or directly messaged Sun Cheng, hoping to go to Jiangcheng for treatment.

Star Hospital, it's on fire.

。 Stealing incense